Which factor has been the PRIMARY driver of the rapid growth in the biosimilar market within the pharmaceutical industry since 2018?

The pharmaceutical industry is witnessing a significant shift with the rise of biosimilars - biological products highly similar to already FDA-approved biologics. This transformation is reshaping market dynamics, pricing strategies, and patient access to critical medications. Test your knowledge about this important market trend that's influencing healthcare economics and treatment accessibility worldwide.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Expiration of patents for major biologic drugs, creating market opportunities for competitors
Mandatory government requirements for hospitals to use biosimilars instead of original biologics
Technological innovations making biosimilars more effective than original biologics
Patient advocacy groups demanding alternatives to traditional chemical medications